European NeuropsychopharmacologyVolume 40, Supplement 1, November 2020, Pages S286-S287P.508 COVID-19 impact on entry symptom severity in schizophrenia clinical trials – preliminary dataAuthor links open overlay panelA. Kott 1, D.G. Daniel 2Show moreShareCitehttps://doi.org/10.1016/j.euroneuro.2020.09.372Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View AbstractCopyright © 2020 Published by Elsevier B.V.